share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Welgus Howard G.

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Welgus Howard G.

Arcutis Biotherapeutics | 4:持股变动声明-董事 Welgus Howard G.
美股SEC公告 ·  12/04 05:22

Moomoo AI 已提取核心信息

On 12/02/2024, Welgus Howard G. completed the sale of 10,000 shares of Arcutis Biotherapeutics common stock. The transaction was executed at a price of $12.51 per share, resulting in a total transaction value of approximately $125,133. This sale was conducted as an open market or private sale.Following this transaction, Welgus Howard G. holds 161,944 shares of Arcutis Biotherapeutics. The transaction was completed directly by the reporting person, with no indirect holdings involved. The sale reflects a strategic decision by the reporting person, impacting their overall shareholding in the company. Investors may consider this transaction as part of their analysis of insider trading activities within Arcutis Biotherapeutics.
On 12/02/2024, Welgus Howard G. completed the sale of 10,000 shares of Arcutis Biotherapeutics common stock. The transaction was executed at a price of $12.51 per share, resulting in a total transaction value of approximately $125,133. This sale was conducted as an open market or private sale.Following this transaction, Welgus Howard G. holds 161,944 shares of Arcutis Biotherapeutics. The transaction was completed directly by the reporting person, with no indirect holdings involved. The sale reflects a strategic decision by the reporting person, impacting their overall shareholding in the company. Investors may consider this transaction as part of their analysis of insider trading activities within Arcutis Biotherapeutics.
2024年2月12日,Welgus Howard G. 完成了10,000股Arcutis Biotherapeutics普通股的出售。该交易以每股12.51美元的价格执行,总交易价值约为125,133美元。此次出售是以公开市场或私人销售的形式进行的。在这笔交易之后,Welgus Howard G. 持有Arcutis Biotherapeutics的161,944股股份。该交易由申报人直接完成,不涉及间接持股。此次出售反映了申报人的战略决策,影响了他们在公司的整体股权。投资者可以将这笔交易视为对Arcutis Biotherapeutics内部交易活动分析的一部分。
2024年2月12日,Welgus Howard G. 完成了10,000股Arcutis Biotherapeutics普通股的出售。该交易以每股12.51美元的价格执行,总交易价值约为125,133美元。此次出售是以公开市场或私人销售的形式进行的。在这笔交易之后,Welgus Howard G. 持有Arcutis Biotherapeutics的161,944股股份。该交易由申报人直接完成,不涉及间接持股。此次出售反映了申报人的战略决策,影响了他们在公司的整体股权。投资者可以将这笔交易视为对Arcutis Biotherapeutics内部交易活动分析的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息